Cost Savings With Clinical Solutions: The Impact of Reforming Health and Health Care Economics With Integrative Therapies

Abstract

Keywords

cost-effectiveness cost savings cancer hypnosis biopsy exercise bone marrow transplant pycnogenol vitamin E thromboembolism

References

Herman PM , Craig BM , Caspi O. Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complement Altern Med. 2005;5:11.

Astin JA , Shapiro SL , Eisenberg DM , Forys KL Mind-body medicine: state of the science, implications for practice . J Am Board Fam Pract. 2003;16:131-147.

Lang EV , Rosen MP Cost analysis of adjunct hypnosis with sedation during outpatient interventional radiologic procedures. Radiology. 2002;222:375-382.

MacBurney M. , Young LS , Ziegler TR , Wilmore DW A cost-evaluation of glutamine-supplemented parenteral nutrition in adult bone marrow transplant patients. J Am Diet Assoc. 1994;94:1263-1266.

Herman PM , Szczurko O. , Cooley K. , Mills EJ Cost-effectiveness of naturopathic care for chronic low back pain . Altern Ther Health Med. 2008;14:32-39.

Fuhr JP Jr , He H. , Goldfarb N. , Nash DB Use of chromium picolinate and biotin in the management of type 2 diabetes: an economic analysis. Dis Manag . 2005;8:265-275.

Montgomery GH , Bovbjerg DH , Schnur JB , et al. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. J Natl Cancer Inst. 2007;99:1304-1312.

Jemal A. , Siegel R. , Ward E. , Hao Y. , Xu J. , Thun MJ Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.

Basic report. http://swz.salary.com/salarywizard/layouthtmls/swzl_compresult_national_hc07000207.html. Accessed April 15, 2010.

10.

Dimeo F. , Bertz H. , Finke J. , Fetscher S. , Mertelsmann R. , Keul J. An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant . 1996;18:1157-1160

11.

Battaglini CL , Hackney AC , Garcia R. , Groff D. , Evans E. , Shea T. The effects of an exercise program in leukemia patients. Integr Cancer Ther . 2009;8:130-138.

12.

Candrilli S. , Mauskopf J. How much does a hospital day cost? http://www.rtihs.org/request/index.cfm?fuseaction=display&PID=6465. Accessed March 12, 2010.

13.

Exercise bikes: reviews. http://www.consumersearch.com/exercise-bike-reviews. Accessed March 12, 2010.

14.

Belcaro G. , Cesarone MR , Genovesi D. , et al. Pycnogenol may alleviate adverse effects in oncologic treatment . Panminerva Med. 2008;50:227-234.

15.

Orlando L. , Colleoni M. , Nolè F. , et al. Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required? Ann Oncol . 2000;11:117-118.

16.

Weiss RB , Tormey DC , Holland JF , Weinberg VE Venous thrombosis during multimodal treatment of primary breast carcinoma . Cancer Treat Rep. 1981;65:677-679.

17.

Heit JA Cancer and venous thromboembolism: scope of the problem. Cancer Control. 2005;12(suppl 1):5-10.

18.

Mandalà M. , Barni S. , Floriani I. , et al. Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the "GISCAD-alternating schedule" study findings. Eur J Cancer. 2009 ;45:65-73.

19.

Mandalà M. , Barni S. , Prins M. , et al. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Ann Oncol. 2010;21:871-876.

20.

Fotopoulou C. , duBois A. , Karavas AN , et al. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. J Clin Oncol. 2008;26:2683-2689.

21.

Yildiz R. , Buyukberber S. , Uner A. , et al. Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens. Cancer Invest. 2010;28:33-37.

22.

Spyropoulos AC , Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm. 2007;13: 475-486.

23.

Khorana AA , Streiff MB , Farge D. , et al. Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol. 2009;27:4919-4926.

24.

Glynn RJ , Ridker PM , Goldhaber SZ , Zee RYL , Buring JE Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women’s Health Study. Circulation. 2007 116: 1497-1503.

25.

DeVol R. , Bedroussian A. An unhealthy America: the economic burden of chronic disease-charting a new course to save lives and increase productivity and economic growth. http://www.milkeninstitute.org/publications/publications.taf?function=detail&ID=38801018&cat=resrep . Accessed May 2, 2010.